Hans Joachim Zentel

Assure IMPD readiness; Preclinical Profiling; Phase 1 Design

Leading cross functional global project teams in Gynecological Therapy, Device Development, Contraception, Ophtalmology, Inflammatory Bowel Disease. Responsibilities include: design and implementation of proof of concept strategies; cooperation with US academic institution.

Leading Portfoliomanagement function within Global Project Management. Integration of portfolio databases Schering AG and Bayer. Reports to head of project office. Direct reports in Berlin and Wuppertal, Germany.

Global Project Leader in multiple therapeutic areas. Located in US headquarters (Berlex Pharmaceuticals, Inc., Montville, NJ, USA). Reported to head of therapeutic area heads, global management boards. Therapeutic areas: Inflammatory Bowel Disease (Leading Global Phase 3 program) Parkinson's Disease (Phase 2, cell therapy, cooperation with US Biotech) CV (Phase 2; cooperation with Japanese Partner) Dermatology (Rosacea, Psoriasis; Phase 3 program; to NDA)

Managed and coordinated activities in multiple early and late stage development projects. Reported to Project Leader and Head of Global Project Management. Working with external partners: Wyeth, Parke-Davis/Warner-Lambert. Develop masterplan for cooperation project, participation in due diligence visit. Set up first homepage for International Project Management.

Coordination of development projects in chemical, pharmaceutical, and analytical development with global project teams, logistics, production, external cooperation partners Therapeutic areas: CNS and Ultrasound-Diagnostics

Leading Compound Finding Program

Post Doctoral Work Neuropeptides, Neuro-Immune axis; RIA, HPLC, IHC

Scientific Work for Diploma Thesis

Endocrinology, Immunology; Zoology; Steroid Metabolism; Developmental Biology;